ATAlbin Tranberg

Albin Tranberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Albin Tranberg has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Administering Antineoplastic Parenteral Cancer Therapy in the Patient's Home: Perspectives of Oncology Nurses—A Descriptive Qualitative Study

    by Tranberg Albin, Kälvemark‐Sporrong Sofia, Paulsson Mattias

    Aim: To explore oncology nurses' perspectives on performing cancer treatments with parenteral antineoplastic agents in patients' homes. Design: A descriptive qualitative study utilizing interviews. Methods: Semi‐structured interviews were performed with oncology nurses at a hospital oncology daycare ward between October and November 2022. The interview data were inductively analysed with thematic content analysis. Results: Five themes were identified: (1) Establishing rapport in the home environment, (2) The complexity of a home, (3) Adverse events—not practicalities, (4) Solitary nursing and (5) Planning enables performance. The nurses believed patients would benefit from home treatment with antineoplastic agents but were concerned about adverse events and working alone. For successful home treatments, nurses believed sufficient resources, education and support were necessary. Practicalities such as transporting, administering and waste handling were not considered complex. Neither did the antineoplastic agents handling seem problematic. Conclusions: Although positive, especially from the patient perspective, the nurses identified concerns that need to be addressed before implementing oncology hospital‐at‐home services. Implications: Working in different contexts than the hospital can lead to extended roles and further responsibilities for oncology nurses and possibly facilitate more person‐centred care. Impact: This study explored oncology nurses' perspectives on performing parenteral cancer treatments with antineoplastic agents in patients' homes. In general, the nurses were positive, but challenges were identified. The study provides insights into how healthcare developers can incorporate the needs of nurses when designing future hospital‐at‐home programmes. Reporting Method: COREQ guidelines were used. Patient or Public Contribution: No patient or public contribution. What Does This Paper Contribute to the Wider Global Clinical Community?: This paper can be used to create tools addressing barriers nurses might have working with hazardous antineoplastic agents in hospital‐at‐home environments. It emphasizes the importance of education, resources and support to provide nurses with an adequate and safe working environment, improving patient experiences and safety.

  • Open Access

    Pharmacists’ views on potential non-medical prescribing for pharmacists in Sweden: a nationwide survey study

    by Nicole Ljungdahl, Sofia Kälvemark-Sporrong, Albin Tranberg, Thomas Kempen

    Introduction: The role of pharmacists in healthcare has evolved, and in several countries, they have prescribing rights. Currently, pharmacists in Sweden do not have the right to prescribe. Exploring their views on pharmacist prescribing may be a critical step toward advancing the profession and improving patient care. Aim: To explore pharmacists’ views on potential pharmacist prescribing in Sweden. Method: An online questionnaire about pharmacist prescribing was distributed via email to Swedish pharmacists who are members of the Swedish Pharmacists Association (n = 5597). The questionnaire covered demographic information and statements about predefined prescribing models, preconditions, benefits, and risks associated with pharmacist prescribing. Each statement had a 4-point agreement Likert scale response option with additional “Don´t know/no opinion” option. Data were collected in May 2024. Closed-ended questions were analyzed descriptively, while open-ended questions were categorized and summarized. Results: Of the 395 respondents (7% response rate), 75.2% (n = 297) agreed with introducing at least one model of pharmacist prescribing. The two models that received the most support were “Prescribing based on an agreement or collaboration with one or more independent prescribers” (50.1%; n = 198) and “Independent, but limited prescribing rights” (48.1%; n = 190). All predefined preconditions were important for the respondents; their education (97.2%, n = 384) was identified as the most important factor. Overall, respondents agreed more with the benefits than the risks of introducing pharmacist prescribing. Most frequently (somewhat) agreeing that an enhanced professional position of pharmacists in health care was a key benefit (91.1%; n = 369), and the risks that respondents most (somewhat) agreed with included increased workload (80.8%; n = 319) and the conflict of interest involved in pharmacists acting as both prescribers and dispensers (60.8%; n = 240). Conclusion: The majority of respondents supported introducing at least one pharmacist prescribing model in Sweden. These findings provide valuable insights for policymakers considering an expanded role for pharmacists in Sweden, which may include a variety of extended professional roles in different settings.